Louise O'toole

Dublin, L, Ireland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Outcomes in Neovascular Age-Related Macular Degeneration with Visit Gaps under Anti-VEGF Therapy in Daily Practice: Data from the Fight Retinal Blindness! Registry.

Outcomes in Neovascular Age-Related Macular Degeneration with Visit Gaps under Anti-VEGF Therapy in Daily Practice: Data from the Fight Retinal Blindness! Registry.

Journal: Ophthalmology. Retina

Published: December 12, 2025

Autosomal Recessive Bestrophinopathy-Phenotypic Variability, Natural History, and Genotype-Phenotype Correlations.

Autosomal Recessive Bestrophinopathy-Phenotypic Variability, Natural History, and Genotype-Phenotype Correlations.

Journal: American journal of ophthalmology

Published: October 08, 2025

Suspending vascular endothelial growth factor inhibitors in eyes with retinal vein occlusion.

Suspending vascular endothelial growth factor inhibitors in eyes with retinal vein occlusion.

Journal: The British journal of ophthalmology

Published: October 04, 2025

Posterior Vitreous Detachment Determines the Clinical Impact of Fibrovascular Membrane Fibrosis After Anti-VEGF Treatment in Proliferative Diabetic Retinopathy: A Real-World Study.

Posterior Vitreous Detachment Determines the Clinical Impact of Fibrovascular Membrane Fibrosis After Anti-VEGF Treatment in Proliferative Diabetic Retinopathy: A Real-World Study.

Journal: Clinical ophthalmology (Auckland, N.Z.)

Published: July 17, 2025

Minimum set of outcome measures for non-advanced age-related macular degeneration: a Delphi consensus statement by the TRACER (intermediate age-related macular degeneration) study group.

Minimum set of outcome measures for non-advanced age-related macular degeneration: a Delphi consensus statement by the TRACER (intermediate age-related macular degeneration) study group.

Journal: The British journal of ophthalmology

Published: April 29, 2025

Impact of AI-enhanced three-dimensional OCT scans on disease activity assessment in patients with nAMD: the RAZORBILL study.

Impact of AI-enhanced three-dimensional OCT scans on disease activity assessment in patients with nAMD: the RAZORBILL study.

Journal: The British journal of ophthalmology

Published: January 16, 2025

Progression of Loss of Vision From Centre-Involving Macular Atrophy in Eyes Treated for nAMD.

Progression of Loss of Vision From Centre-Involving Macular Atrophy in Eyes Treated for nAMD.

Journal: Clinical & experimental ophthalmology

Published: January 08, 2025

Patients' awareness and presenting symptoms at the onset of neovascular age-related macular degeneration in two distinct European cohorts.

Patients' awareness and presenting symptoms at the onset of neovascular age-related macular degeneration in two distinct European cohorts.

Journal: International ophthalmology

Published: December 04, 2024

Outliers of Treatment Frequency in Retinal Vein Occlusion: 24-Month Comparative Analysis of Fight Retinal Blindness! Practitioners.

Outliers of Treatment Frequency in Retinal Vein Occlusion: 24-Month Comparative Analysis of Fight Retinal Blindness! Practitioners.

Journal: Clinical & experimental ophthalmology

Published: August 25, 2024

Impact of cataract surgery on patients receiving intravitreal therapy for retinal vein occlusion.

Impact of cataract surgery on patients receiving intravitreal therapy for retinal vein occlusion.

Journal: Clinical & experimental ophthalmology

Published: August 12, 2024

Addressing Technical Failures in a Diabetic Retinopathy Screening Program [Response to Letter].

Addressing Technical Failures in a Diabetic Retinopathy Screening Program [Response to Letter].

Journal: Clinical ophthalmology (Auckland, N.Z.)

Published: March 18, 2024

Treat-and-Extend Versus Pro re nata Regimens of Ranibizumab and Aflibercept in Neovascular Age-Related Macular Degeneration: A Comparative Study from Routine Clinical Practice.

Treat-and-Extend Versus Pro re nata Regimens of Ranibizumab and Aflibercept in Neovascular Age-Related Macular Degeneration: A Comparative Study from Routine Clinical Practice.

Journal: Ophthalmology and therapy

Published: January 18, 2024

Showing 1-12 of 36

Last Updated: 09/26/2026